[Form 4] Semtech Corp Insider Trading Activity
Gregory M. Fischer, a director of Semtech Corp (SMTC), reported sales of a total of 1,500 shares of Semtech common stock on 08/29/2025 under a Rule 10b5-1 trading plan adopted May 30, 2025. The report lists three sale transactions: 1,268 shares at a weighted average price of $58.2508, 219 shares at $59.4205, and 13 shares at $59.8719. Following these dispositions, Mr. Fischer beneficially owns 3,891 shares of Semtech common stock. The Form 4 was signed on behalf of Mr. Fischer by Mark Lin under a power of attorney and filed on 09/02/2025. The filing explicitly notes the price ranges for each tranche and that detailed price and share breakdowns are available upon request.
- Transactions executed under a Rule 10b5-1 plan, providing an affirmative defense and procedural clarity
- Detailed weighted-average prices and price ranges disclosed, enhancing transparency about execution
- None.
Insights
TL;DR: Director sold 1,500 shares via a pre-established 10b5-1 plan; post-sale ownership 3,891 shares—routine insider liquidity.
The filing documents three discrete sale transactions executed on 08/29/2025 pursuant to a Rule 10b5-1 plan adopted May 30, 2025. The weighted average prices for the tranches are provided and price ranges are disclosed, supporting transparency about execution. The transaction is reported on a Form 4 with a power-of-attorney signature. From a financial reporting perspective, this is a standard disclosure of insider sales and does not include additional information on motivations or company operational impact.
TL;DR: Insider sales were executed under a documented 10b5-1 plan, consistent with governance best practices for scheduled trades.
The disclosure clarifies that the trades were made pursuant to an established 10b5-1 plan, which helps provide an affirmative defense under Rule 10b5-1(c). The Form 4 identifies the reporting person as a director and records post-transaction beneficial ownership. The presence of a power-of-attorney signature and explicit price ranges increases procedural transparency. The filing does not indicate any change in role or other governance actions.